You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Assessing medication adherence: options to consider
|
|---|---|
| Published in |
International Journal of Clinical Pharmacy, October 2013
|
| DOI | 10.1007/s11096-013-9865-x |
| Pubmed ID | |
| Authors |
Audrey Lehmann, Parisa Aslani, Rana Ahmed, Jennifer Celio, Aurelie Gauchet, Pierrick Bedouch, Olivier Bugnon, Benoît Allenet, Marie Paule Schneider |
| Abstract |
Adherence to chronic therapy is a key determinant of patient health outcomes in chronic disease. However, only about 50 % of patients adhere to chronic therapy. One of the challenges in promoting adherence is having an accurate understanding of adherence rates and the factors that contribute to non-adherence. There are many measures available to assess patient medication adherence. |
X Demographics
The data shown below were collected from the profiles of 19 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 8 | 42% |
| Argentina | 1 | 5% |
| Venezuela, Bolivarian Republic of | 1 | 5% |
| Unknown | 9 | 47% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 15 | 79% |
| Practitioners (doctors, other healthcare professionals) | 3 | 16% |
| Scientists | 1 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 390 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Switzerland | 1 | <1% |
| Malaysia | 1 | <1% |
| Hong Kong | 1 | <1% |
| Australia | 1 | <1% |
| South Africa | 1 | <1% |
| Spain | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 383 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 84 | 22% |
| Student > Ph. D. Student | 59 | 15% |
| Student > Bachelor | 38 | 10% |
| Researcher | 31 | 8% |
| Student > Doctoral Student | 23 | 6% |
| Other | 75 | 19% |
| Unknown | 80 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 111 | 28% |
| Pharmacology, Toxicology and Pharmaceutical Science | 61 | 16% |
| Psychology | 28 | 7% |
| Computer Science | 23 | 6% |
| Nursing and Health Professions | 22 | 6% |
| Other | 50 | 13% |
| Unknown | 95 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 37. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 November 2023.
All research outputs
#1,108,409
of 25,649,244 outputs
Outputs from International Journal of Clinical Pharmacy
#28
of 1,595 outputs
Outputs of similar age
#9,886
of 226,136 outputs
Outputs of similar age from International Journal of Clinical Pharmacy
#2
of 29 outputs
Altmetric has tracked 25,649,244 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,595 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 226,136 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 29 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.